Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Cerebral venous thrombosis due to cryptogenic organising pneumopathy with antiphospholipid syndrome worsened by heparin-induced thrombocytopenia.

Hsieh J, Kuzmanovic I, Vargas MI, Momjian-Mayor I.

BMJ Case Rep. 2013 Jul 9;2013. pii: bcr2013009500. doi: 10.1136/bcr-2013-009500.

PMID:
23843405
[PubMed - indexed for MEDLINE]
2.

Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis.

Richard S, Perrin J, Lavandier K, Lacour JC, Ducrocq X.

Platelets. 2011;22(2):157-9. doi: 10.3109/09537104.2010.527399. Epub 2010 Dec 8.

PMID:
21142409
[PubMed - indexed for MEDLINE]
3.

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.

Perunicic J, Antonijevic NM, Miljic P, Djordjevic V, Mikovic D, Kovac M, Djokic M, Mrdovic I, Nikolic A, Vasiljevic Z.

J Thromb Thrombolysis. 2008 Oct;26(2):142-6. Epub 2007 Sep 9.

PMID:
17828468
[PubMed - indexed for MEDLINE]
4.

Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.

Tokgoz H, Caliskan U, Demir M.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):769-71. doi: 10.1097/MBC.0b013e328358afc9.

PMID:
22964766
[PubMed - indexed for MEDLINE]
5.

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

Fabris F, Luzzatto G, Soini B, Ramon R, Scandellari R, Randi ML, Girolami A.

J Intern Med. 2002 Aug;252(2):149-54.

PMID:
12190890
[PubMed - indexed for MEDLINE]
6.

Venous thromboembolism in heparin-induced thrombocytopenia.

Warkentin TE.

Curr Opin Pulm Med. 2000 Jul;6(4):343-51. Review.

PMID:
10912644
[PubMed - indexed for MEDLINE]
7.

Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis.

Appenzeller S, Zeller CB, Annichino-Bizzachi JM, Costallat LT, Deus-Silva L, Voetsch B, Faria AV, Zanardi VA, Damasceno BP, Cendes F.

Clin Neurol Neurosurg. 2005 Aug;107(5):371-8. Epub 2004 Nov 18.

PMID:
16023530
[PubMed - indexed for MEDLINE]
8.

Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.

Lobo B, Finch C, Howard A, Minhas S.

Thromb Haemost. 2008 Jan;99(1):208-14. doi: 10.1160/TH07-04-0252.

PMID:
18217156
[PubMed - indexed for MEDLINE]
9.

Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.

Pendleton R, Wheeler MM, Rodgers GM.

Ann Pharmacother. 2006 May;40(5):972-6. Epub 2006 Mar 28. Erratum in: Ann Pharmacother. 2006 Jul-Aug;40(7-8):1477.

PMID:
16569813
[PubMed - indexed for MEDLINE]
10.

Catastrophic thromboses and severe thrombocytopenia during heparin therapy in a patient with anti-phospholipid syndrome.

Zeller L, Almog Y, Tomer A, Sukenik S, Abu-Shakra M.

Clin Rheumatol. 2006 May;25(3):426-9. Epub 2005 Oct 6.

PMID:
16208430
[PubMed - indexed for MEDLINE]
11.

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.

Junqueira DR, Perini E, Penholati RR, Carvalho MG.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD007557. doi: 10.1002/14651858.CD007557.pub2. Review.

PMID:
22972111
[PubMed - indexed for MEDLINE]
12.

Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.

Opatrny L, Warner MN.

Am J Hematol. 2004 Jul;76(3):240-4.

PMID:
15224359
[PubMed - indexed for MEDLINE]
13.

Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.

Warkentin TE.

Thromb Haemost. 2008 Jan;99(1):2-3. doi: 10.1160/TH07-12-0713. No abstract available.

PMID:
18217128
[PubMed - indexed for MEDLINE]
14.

The approach to heparin-induced thrombocytopenia.

Linkins LA, Warkentin TE.

Semin Respir Crit Care Med. 2008 Feb;29(1):66-74. doi: 10.1055/s-2008-1047564. Review.

PMID:
18302088
[PubMed - indexed for MEDLINE]
15.

False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus.

Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U.

J Thromb Haemost. 2009 Jul;7(7):1070-4. doi: 10.1111/j.1538-7836.2009.03335.x. Epub 2009 Mar 5.

PMID:
19291166
[PubMed - indexed for MEDLINE]
16.

[Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].

Gavranić BB, Basić-Jukić N, Kes P.

Acta Med Croatica. 2012 Oct;66 Suppl 2:68-71. Croatian.

PMID:
23513420
[PubMed - indexed for MEDLINE]
17.

Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome.

Warkentin TE, Aird WC, Rand JH.

Hematology Am Soc Hematol Educ Program. 2003:497-519. Review.

PMID:
14633796
[PubMed - indexed for MEDLINE]
Free Article
18.

Heparin-induced thrombocytopenia.

Greinacher A, Althaus K, Krauel K, Selleng S.

Hamostaseologie. 2010 Jan;30(1):17-8, 20-8. Review.

PMID:
20162249
[PubMed - indexed for MEDLINE]
19.

Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.

Wester JP, Haas FJ, Biesma DH, Leusink JA, Veth G.

Intensive Care Med. 2004 Oct;30(10):1927-34. Epub 2004 May 20.

PMID:
15156309
[PubMed - indexed for MEDLINE]
20.

Venous thrombosis: preventing clots in patients at risk.

Phillippe HM, Sparkman AY.

J Fam Pract. 2010 Jun;59(6):315-21. No abstract available.

PMID:
20544063
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk